Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Therapeutic Delivery|October 6, 2012
Predicting feasibility and characterizing performance of extended-release formulations using physiologically based pharmacokinetic modelingJonathan Brown, John Crison, Peter TimminsPharmaceutics|October 27, 2022
Unexpected Stability of a Prodrug to Enzymatic Hydrolysis within a Hydrated HPMC Matrix TabletSarah Hanley, Jonathan Brown, Peter Timmins, et al.Molecular Pharmaceutics|February 19, 2020
Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR ImagingFarah Deeba Zahoor, Kerstin T Mader, Peter Timmins, et al.Therapeutic Delivery|July 23, 2016
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tabletsPeter Timmins, Divyakant Desai, Wei Chen, et al.The AAPS Journal|May 31, 2012
The use of modeling tools to drive efficient oral product designNeil R Mathias, John CrisonMolecular Pharmaceutics|November 5, 2015
Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic AnalysisDavid J Good, Ruiling Hartley, Neil Mathias, et al.Drug Discovery Today|April 15, 2014
Enabled clinical use of an HIV-1 attachment inhibitor through drug deliveryPeter Timmins, Jonathan Brown, Nicholas A Meanwell, et al.International Journal of Pharmaceutics|February 27, 2018
Monitoring of multiple solvent induced form changes during high shear wet granulation and drying processes using online Raman spectroscopyJay Poorna Reddy, John W Jones, Patrick S Wray, et al.Therapeutic Delivery|March 13, 2026
Industry update: the latest developments in the field of therapeutic delivery, December 2025Peter TimminsJournal of Pharmaceutical Sciences|May 18, 2013
Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrugJonathan Brown, Caly Chien, Peter Timmins, et al.Pageof 17